What Is the Best Drug for Erectile Dysfunction?

No single drug is universally “best” for erectile dysfunction, but the class of medications called PDE5 inhibitors dominates the field, and among them, tadalafil and vardenafil consistently rank as the most effective in head-to-head analyses. The choice between the available options depends less on raw effectiveness and more on how you live: how spontaneous you want sex to be, what other medications you take, and whether you prefer a drug that works fast or one that stays active for a day and a half. The differences between the top contenders are real but surprisingly narrow, which is why the “best” drug often comes down to personal fit rather than pharmacological superiority.

How PDE5 Inhibitors Work

An erection depends on blood flow. When you’re sexually aroused, nerve and blood-vessel cells in the penis release nitric oxide, which triggers a chain of events that relaxes smooth muscle in the erectile tissue and lets blood rush in. A signaling molecule called cGMP is the key player that keeps that muscle relaxed and maintains the erection.¹ The body naturally breaks down cGMP using an enzyme called PDE5. All the major ED drugs work by blocking that enzyme, so cGMP sticks around longer and blood flow to the penis is sustained.²

One thing worth understanding is that these drugs do not create arousal on their own. They amplify the body’s natural response to sexual stimulation. Without that initial spark of arousal, the pill will not produce an erection. This is a common source of frustration for men who expect the drug to work like an on-off switch.

Comparing Sildenafil, Tadalafil, and Vardenafil

Sildenafil (Viagra) was the first PDE5 inhibitor, approved in the late 1990s after being developed originally as a heart medication.³ In its first major trials, about three-quarters to four-fifths of men reported improved erections at doses of 50 to 100 mg.⁴ Vardenafil (Levitra) and tadalafil (Cialis) followed within a few years, and clinical comparisons showed similar effectiveness across the three drugs for most men.

Where the drugs diverge is in their pharmacology. Sildenafil and vardenafil both kick in within about 30 to 60 minutes and last roughly four to six hours. Tadalafil takes a bit longer to reach full effect but stays active for up to 36 hours, earning it the nickname “the weekend pill.”⁵ That long window means less pressure to time the pill precisely before sex, which is the main reason men tend to prefer tadalafil over sildenafil in preference studies.⁴

A large network meta-analysis that pooled data from many trials and compared all the available PDE5 inhibitors found that tadalafil and vardenafil ranked as the most effective across multiple outcome measures. Tadalafil scored higher than vardenafil on standardized erectile-function scales, and both outperformed newer agents like avanafil and udenafil. The safety profiles were broadly similar across all the drugs.⁶ Vardenafil has a slight edge in potency at the cellular level, which some researchers interpret as an advantage in certain difficult-to-treat cases.⁵

There is also avanafil (Stendra), a newer PDE5 inhibitor designed specifically for faster onset. It can take effect in as little as 15 minutes for some men, which is appealing for spontaneity. However, it performed less well than tadalafil and vardenafil in the network meta-analysis mentioned above, and its shorter track record means fewer long-term data are available.⁶

Daily Dosing vs. Taking a Pill Before Sex

Most men start with “on-demand” dosing, taking a pill an hour or so before sex. But tadalafil is also approved in a lower daily dose (typically 2.5 or 5 mg), and there is growing evidence that daily use may work better for some men. In a randomized trial comparing on-demand tadalafil at 20 mg to daily tadalafil at 10 mg, men on the daily regimen had higher rates of successful intercourse (about 84% vs. 69%) and greater improvement in erectile function scores.⁷ A more recent randomized study confirmed that daily tadalafil outperformed both on-demand tadalafil and on-demand sildenafil in penetration success.⁸

Daily dosing eliminates the need to plan around a pill, which some couples find psychologically freeing. It also maintains a steady level of the drug in the body, which may explain the slightly better results. Tadalafil’s long half-life makes it uniquely suited for this approach; sildenafil and vardenafil clear the body too quickly to work well as daily drugs. The tradeoff is cost, since you’re taking a pill every day rather than a few times a month, though generic tadalafil has made this more affordable than it once was.

Daily tadalafil also has a secondary benefit: it is approved to treat the urinary symptoms of an enlarged prostate (benign prostatic hyperplasia). Men dealing with both conditions may find that one daily pill addresses both, which simplifies treatment.

Safety Rules That Apply to All PDE5 Inhibitors

The single most important safety rule is that PDE5 inhibitors must never be combined with nitrate medications, such as nitroglycerin, isosorbide dinitrate, or isosorbide mononitrate, commonly prescribed for chest pain. Nitrates and PDE5 inhibitors both lower blood pressure through overlapping mechanisms, and the combination can cause a dangerous, prolonged drop in blood pressure and reduced blood flow to the heart.⁹ This interaction is not a theoretical risk; it is a hard contraindication that applies to all drugs in the class.¹⁰

The duration of this interaction varies by drug, and this matters practically. With sildenafil or vardenafil, the blood-pressure interaction with nitroglycerin fades within about 24 hours. With tadalafil, because it lingers in the body longer, the interaction persists for about 24 hours and is not reliably gone until 48 hours after the dose.¹¹ For men with coronary artery disease who might need emergency nitroglycerin, this longer window with tadalafil is a genuine clinical consideration and a reason a doctor might steer toward sildenafil or vardenafil instead.

Outside of the nitrate interaction, PDE5 inhibitors have a strong safety record. Multiple analyses have found they do not increase heart attack or death rates compared to placebo or age-matched populations, and some research suggests they may even have cardiovascular benefits.¹⁰ Common side effects tend to be mild: headache, flushing, nasal congestion, and indigestion. Sildenafil can cause a blue-tinged tint to vision in some men. These effects generally fade as the drug wears off.

ED in Men With Diabetes or After Prostate Surgery

Erectile dysfunction is much more common in men with diabetes because elevated blood sugar damages blood vessels and nerves over time. PDE5 inhibitors remain the first-line treatment for diabetic men, and they are generally effective and safe in this population, though response rates tend to be somewhat lower than in the general population because the underlying vascular damage is more extensive.⁵

After radical prostatectomy (surgical removal of the prostate, usually for cancer), erectile dysfunction is extremely common because the nerves controlling erection run along the prostate and are often damaged during surgery. The idea of “penile rehabilitation,” using daily PDE5 inhibitors or other treatments early after surgery to preserve the tissue’s ability to function, has been widely adopted by urologists. However, the evidence is less encouraging than the enthusiasm. A Cochrane review found that scheduled PDE5 inhibitor use after prostatectomy showed little to no benefit for self-reported potency compared to on-demand use, and the evidence was rated as very low quality.¹² Basic science supports the rationale for early treatment, but clinical trials have produced conflicting results about whether it actually helps long-term.¹³ Intraurethral alprostadil has also been studied in this setting and appears comparably effective to sildenafil within the first year after nerve-sparing surgery.¹⁴

When Pills Are Not Enough

About a quarter to a third of men do not respond adequately to PDE5 inhibitors. Before declaring the drugs a failure, it is worth making sure they were used correctly: taking the pill on an empty stomach (for sildenafil and vardenafil), allowing enough time for onset, and attempting intercourse on multiple occasions rather than giving up after one try. Sometimes switching from one PDE5 inhibitor to another or moving from on-demand to daily dosing makes the difference.

For men with low testosterone who do not respond well to a PDE5 inhibitor alone, adding testosterone therapy can rescue the response. A randomized trial found that combining testosterone gel with sildenafil significantly improved erectile function and satisfaction in men who had failed sildenafil on its own.¹⁵ A systematic review of the combined approach confirmed that testosterone repletion enhanced the effect of PDE5 inhibitors in men with testosterone levels below about 300 ng/dL, though the overall study quality was mixed.¹⁶

If oral drugs still do not work, the next step is usually alprostadil, a synthetic form of prostaglandin E1 that directly relaxes the blood vessels in the penis. It can be delivered as an injection into the side of the penis (intracavernosal injection) or as a tiny pellet inserted into the urethra. The injection approach is highly effective: in a six-month study, men reported being able to have sex after 94% of injections, with both men and their partners rating the experience satisfactory about 87% of the time. The main downsides are penile pain (mild, occurring after about 11% of injections) and the psychological barrier of injecting into your own penis.¹⁷ The intraurethral version avoids needles and has a good safety profile with no reports of the scarring that can sometimes occur with injections, and patients generally prefer it for ease of use.¹⁸

The Role of Psychology in Treatment

Erectile dysfunction is rarely purely physical or purely psychological; most cases involve some mix. Performance anxiety, relationship stress, and depression can cause or worsen ED, and even when the root cause is physical, the repeated experience of failed erections creates a psychological overlay that makes things worse. For men with primarily psychogenic ED, combining psychological therapy with a PDE5 inhibitor outperforms either approach alone. A systematic review found that men receiving both psychotherapy and sildenafil had better outcomes and were less likely to drop out of treatment than those on sildenafil alone.¹⁹ Combined interventions were also significantly better for long-term sexual satisfaction.²⁰

This is an underappreciated finding. Many men think of ED treatment as strictly a medication issue, and many prescribers hand over a prescription without discussing the psychological dimension. For younger men especially, where anxiety is often a major contributor, a pill alone may produce erections but fail to address the deeper cycle of worry and avoidance that sustains the problem.

Why “Natural” ED Supplements Are a Gamble

Walk through a gas station or scroll through certain online retailers and you’ll find shelves of products marketed as “natural male enhancement.” These supplements sit in a regulatory gray zone. They are sold as dietary supplements, which means they do not undergo the same testing and approval process as prescription drugs. Many consumers assume “natural” or “herbal” means safer, but testing repeatedly tells a different story.

When researchers analyzed 91 samples of purported herbal enhancement products, 81% contained undeclared pharmaceutical ingredients, primarily tadalafil and sildenafil. Nearly a fifth of those samples contained more than 110% of the highest approved prescription dose. Labeling was often inadequate or inconsistent between batches of the same product, and only a small minority included any warning about the potentially lethal interaction with nitrate medications.²¹ Other analyses have confirmed that adulteration of these supplements with PDE5 inhibitors or their chemical cousins is extremely common and poses a genuine public health risk.²² These products may contain unknown quantities of active drug ingredients with no quality control during manufacturing.²³

The irony is stark: many men reach for these products specifically to avoid taking a “chemical” drug, not knowing they are getting the same chemical drug in an uncontrolled dose. If a man on nitrates takes one of these products without knowing it contains sildenafil, the result could be a medical emergency. The safer path is always a prescription from someone who knows your medical history.

The Direct-to-Consumer Convenience Question

Online telehealth platforms have made getting ED prescriptions easier than ever, often with a brief questionnaire and a virtual visit instead of an in-person appointment. The convenience is real, and for men who find the topic embarrassing to discuss face to face, these services lower a meaningful barrier. However, research has shown that medications purchased through these direct-to-consumer platforms often come at a significant markup compared to filling a prescription at a traditional pharmacy.²⁴ With generic sildenafil and tadalafil widely available, a local pharmacy with a standard prescription is often considerably cheaper. It is worth comparing prices before committing to a subscription service.

Treatments on the Horizon

PDE5 inhibitors have dominated ED treatment for over two decades, but several novel approaches are in various stages of development. Low-intensity shockwave therapy aims to stimulate new blood vessel growth in the penis, potentially restoring natural erectile function rather than simply managing symptoms. Early results from clinical trials, including a randomized controlled study, have shown significant improvements in erectile function and penile blood flow without adverse effects.²⁵ The concept is appealing because it targets the underlying vascular problem rather than working around it, though the therapy is still considered investigational and protocols are not yet standardized.

Other experimental directions include melanocortin receptor agonists, which act through the brain rather than the blood vessels and can initiate erections without sexual stimulation, making them potentially useful for men who do not respond to PDE5 inhibitors. Stem cell therapy has shown favorable early data in men with diabetic or post-surgical ED. And various new molecules targeting alternative signaling pathways in the erectile tissue are being explored as potential complements or alternatives to existing drugs.²⁶ None of these are ready for prime time yet, but they suggest the treatment landscape will eventually expand beyond the current pill-or-injection options.